VKTX Today - Aug 13: Obesity Pipeline Buzz

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

VKTX Today - Aug 13: Obesity Pipeline Buzz

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey, your friendly neighborhood investor, and I’m here to break down what went down with Viking Therapeutics today. Spoiler alert: it was a red day for VKTX, dropping about 2.6%.

So, here’s the scoop. VKTX started off the day looking pretty solid but then hit a bit of a wall. By the time the market closed, it was down almost a buck. Just a rough ride overall, you know?

Now, why the dip? Well, there’s a mix of vibes going on. On one hand, there was some buzz about their obesity pipeline. People were feeling optimistic, thinking that could lead to good things. But then, bam! JPMorgan dropped a not-so-great forecast for the stock, which definitely made folks a bit skittish. It’s like one step forward, two steps back, right? And, just to throw a little more spice into the mix, they’ve been expanding their at-the-market offerings, which can sometimes make investors raise an eyebrow. So yeah, a lot of back and forth today.

Looking ahead, it’s worth knowing that JPMorgan still has a price target of $65 on VKTX, even after lowering it. So, there’s still some belief in the long-term potential here, despite today’s hiccup.

Alright, that’s the rundown on VKTX for today. Just remember, I'm here to keep you in the loop, not to dish out any financial advice. So, keep it chill and happy investing, friends!

まだレビューはありません